A prospective, 12-month observational study of attendance to a multi-disciplinary tertiary vulvar clinic in South Australia

A double-blinded, single-centre, randomised controlled trial to compare the efficacy and safety of oral deucravacitinib, a novel selective TYK-2 inhibitor, to that of methotrexate, in patients with vulvar lichen planus who have failed topical therapy with potent corticosteroids

Characterising predictive factors for requirement for systemic immunosuppressive treatment in vulvovaginal lichen planus and quality of life compared to those treated with topical corticosteroids

The barriers and perceived benefits to Vulvar Self-Examination (VSE) in the management of vulval lichen sclerosus

Mapping the burden of skin disease: Scabies prevalence in a remote Aboriginal community in the Northern Territory conducted alongside a mass-drug administration treatment program

Clinical update: Ivermectin access for scabies improved through PBS change in Australia